Download annotations/test/wsi_bench/Grading_test.json from WinstonHu/LoC-Path-Data: direct link, hf CLI and curl.
- Browser
- Download file 85.3 kB
-
https://huggingface.co/datasets/WinstonHu/LoC-Path-Data/resolve/main/annotations/test/wsi_bench/Grading_test.json
- Command line
-
hf download hf://datasets/WinstonHu/LoC-Path-Data/annotations/test/wsi_bench/Grading_test.json
-
curl -L -o Grading_test.json https://huggingface.co/datasets/WinstonHu/LoC-Path-Data/resolve/main/annotations/test/wsi_bench/Grading_test.json
85.3 kB
| [ | |
| { | |
| "id": "TCGA-21-1083-01Z-00-DX1.8288ca92-b611-4acf-986e-0b8a3f620b94-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading for this squamous cell carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This squamous cell carcinoma is graded as Grade III, indicating poorly differentiated cells. This grade is characterized by highly disorganized cell arrangements and pronounced nuclear pleomorphism, which reflect a higher degree of malignancy and poorer differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-21-1083-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-85-A4QR-01Z-00-DX1.B5E18F89-D5B4-4F51-BC7E-9FA868A6A443-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma according to the slide observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This squamous cell carcinoma is graded as G-2, indicating moderate differentiation. This assessment is supported by the formation of keratin pearls, moderate nuclear variability, and the characteristic architecture of the malignant squamous cells, reflecting an intermediate level of aggressiveness." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-85-A4QR-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-98-A53H-01Z-00-DX1.B05E6339-440C-4F2E-95B5-F2C96413D488-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma as noted in the observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The squamous cell carcinoma is graded as moderately differentiated. This grading reflects moderate nuclear pleomorphism and mitotic activity, alongside differentiation that retains recognizable squamous traits such as keratinization and intercellular bridges." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-98-A53H-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-66-2788-01Z-00-DX1.1a57324a-5b00-44ed-912d-9522d0141500-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading for this carcinoma according to the provided observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is slightly to moderately differentiated, reflecting the presence of atypical, yet somewhat organized epithelial cell structures. The degree of differentiation suggests that the tumor retains some features of the original tissue while exhibiting significant atypical characteristics." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-66-2788-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-22-5481-01Z-00-DX1.6BB77BD0-92FF-43FF-A86C-9EF41B2921DA-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This squamous cell carcinoma is graded as Grade 4 (of 4), indicating a poorly differentiated tumor. The high grade corresponds with minimal keratinization and marked cellular atypia, alongside significant necrosis and lymphovascular invasion, indicative of the tumor's aggressive and advanced nature." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-22-5481-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-85-A4CL-01Z-00-DX1.05BC31FF-3B88-489F-9BD2-5B2B31C72EDB-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This squamous cell carcinoma is designated as Grade 3 (G3), which indicates a poorly differentiated tumor. This grading reflects the lack of keratinization, extensive nuclear pleomorphism, and high mitotic activity, characterizing a highly aggressive malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-85-A4CL-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-EQ-5647-01Z-00-DX1.e71da6e6-dd3d-4fb3-b1ba-ada25e6319bb-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as moderately differentiated. This assessment reflects the moderate deviations in the glandular structures from normal architecture and the variability in nuclear morphology, indicating a moderate degree of differentiation and malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-EQ-5647-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BR-8081-01Z-00-DX1.c6c1ef86-9aad-463e-a64a-f1a2dbe465dc-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This adenocarcinoma is considered moderately differentiated. This grading reflects the moderate preservation of glandular architecture and the moderate variability in nuclear features, suggesting an intermediate level of differentiation within the tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-BR-8081-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-VQ-A8P8-01Z-00-DX1.85D05076-70BE-46A6-B866-94846CD22670-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat grade would you assign to this intestinal-type adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is moderately differentiated, which generally corresponds to an intermediate grade. This means that the tumor cells still retain some characteristics of the original glandular tissue but show enough atypical features to indicate a significant deviation from normal architecture and behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-VQ-A8P8-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-VQ-A91Z-01Z-00-DX1.14F618B5-D177-4129-A7C1-99373536DE45-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the level of differentiation observed in this adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma observed in this slide is moderately differentiated. This indicates that the tumor retains some glandular structures and characteristics, though with an evident deviation from normal tissue architecture and function." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-VQ-A91Z-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-5R-AA1C-01Z-00-DX1.DC038B55-4002-406D-B9DD-2A4BFDB03A61-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat does the Metavir fibrosis score of 1 and Knodell histological activity index score of 1 indicate about the surrounding liver tissue?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Metavir fibrosis score of 1 indicates early-stage fibrosis, meaning there is slight fibrotic tissue development around portal areas without significant bridging fibrosis. The Knodell histological activity index score of 1 suggests minimal necroinflammatory activity, indicating a low level of liver inflammation and necrosis in the surrounding tissue." | |
| } | |
| ], | |
| "image": [ | |
| "./LIHC/TCGA-5R-AA1C-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DD-A11C-01Z-00-DX1.FBF80337-ED73-4611-8E0F-F3FE8A666DB9-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of the hepatocellular carcinoma based on the provided details?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is graded as histologic grade 3 out of 4, reflecting a poorly differentiated tumor. This grading is supported by the extensive nuclear atypia, considerable deviations from typical architectural patterns, and evident aggressive traits such as increased mitotic activity and vascular invasion." | |
| } | |
| ], | |
| "image": [ | |
| "./LIHC/TCGA-DD-A11C-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DD-AADR-01Z-00-DX1.A29CD802-5F9B-49FD-96AA-8B06E97442BE-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the worst degree of differentiation noted in this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The worst area of differentiation is classified as grade III. This indicates a higher degree of anaplasia and a greater departure from normal hepatocyte morphology, suggestive of a more aggressive portion within the tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./LIHC/TCGA-DD-AADR-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DD-A119-01Z-00-DX1.3FB0547B-D84A-4103-8238-4BF504429371-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow would you grade this hepatocellular carcinoma based on the provided information?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The hepatocellular carcinoma is graded as Grade 3 (of 4). This grading reflects the poorly differentiated characteristics of the tumor, indicating a high degree of malignancy and aggressive clinical behavior. The presence of extratumoral vascular invasion and the extent of tissue disruption further corroborate this high-grade classification." | |
| } | |
| ], | |
| "image": [ | |
| "./LIHC/TCGA-DD-A119-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-G3-AAV7-01Z-00-DX1.111A52E5-5FBA-4340-9246-FEFA8BC71CCF-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on the specified details?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as moderately differentiated, indicating intermediate differentiation between well and poorly differentiated carcinoma. This reflects a moderate level of architectural and cytological deviation from normal hepatocytes, demonstrated by the trabecular pattern and nuclear atypia." | |
| } | |
| ], | |
| "image": [ | |
| "./LIHC/TCGA-G3-AAV7-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-IA-A40Y-01Z-00-DX1.E8D91A02-A0BD-4974-8CF9-68DC1AF506EF-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this renal cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This renal cell carcinoma has been assigned a Fuhrman nuclear grade of 4. This grade reflects the marked nuclear irregularity, with highly pleomorphic and atypical nuclei, as well as prominent nucleoli, indicating a high degree of malignancy and aggressiveness." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRP/TCGA-IA-A40Y-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-G7-A8LD-01Z-00-DX1.1CC1D9FD-11D7-4E38-8AB7-34BF23C95D65-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman Nuclear Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Fuhrman Nuclear Grade 3. This reflects significant nuclear irregularity, large nucleoli, and a high degree of nuclear atypia, indicating an aggressive tumor phenotype." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRP/TCGA-G7-A8LD-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BQ-5886-01Z-00-DX1.7a12ddce-2ece-46d3-bc42-12ec540d0ffe-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nCan you determine the Fuhrman nuclear grading for this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as Fuhrman nuclear grade III, characterized by significant nuclear variability in size and shape, indicative of a higher degree of nuclear atypia and aggressive tumor behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRP/TCGA-BQ-5886-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-2Z-A9JI-01Z-00-DX1.41A4F992-87D9-43A4-8776-D11BF5EB1123-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor exhibits a Fuhrman nuclear grade of 3 out of 4, indicating marked nuclear enlargement and irregularity, which correlates with a higher degree of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRP/TCGA-2Z-A9JI-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-GL-A59T-01Z-00-DX1.93128005-E121-4B81-9E9E-B05EAB93230E-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman grade of this renal cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The renal cell carcinoma is classified as Fuhrman grade 2 of 4. This grading reflects moderate nuclear features, with small, oval nuclei present in the papillary structures, and is considered in conjunction with other observed histological characteristics." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRP/TCGA-GL-A59T-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CJ-4920-01Z-00-DX1.103EF882-1E2D-443D-AEBC-EFC39CD5376F-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this renal cell carcinoma based on the observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The renal cell carcinoma is given a Fuhrman nuclear grade of 2. This grading reflects the moderately distinct nucleoli observable at high power, indicating an intermediate level of nuclear atypia and aggressiveness." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-CJ-4920-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-B0-4846-01Z-00-DX1.7552759a-fa5b-425f-8db1-33fe6f871f6b-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this renal cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman nuclear grade for this tumor is 2 out of 4. This grading is based on the moderate variability in nuclear size and shape, indicating moderate nuclear atypia." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-B0-4846-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CZ-5462-01Z-00-DX1.270f84aa-9ae5-4de7-adb3-8b3ea53aeba1-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of the tumor as observed?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman nuclear grade of the tumor is III/IV. This is characterized by marked nuclear atypia, larger nuclei, and prominent nucleoli, reflecting a higher grade of malignancy and correlating with a more aggressive clinical behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-CZ-5462-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BP-4798-01Z-00-DX1.5f6fa5de-bdbc-4048-9948-c89a25a92fd5-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade for this case, and what are its indicative features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman nuclear grade for this tumor is Grade IV. This grade is characterized by prominent nuclear atypia, notable pleomorphic nuclei and large, prominent nucleoli. The degree of nuclear abnormalities correlates with high-grade aggressive behavior in renal cell carcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-BP-4798-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BP-4999-01Z-00-DX1.e78eaded-4e89-4bcf-b3fe-3e7b8db7f2c2-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman grading determined for this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman Nuclear Grade is IV, reflecting the marked pleomorphism of the nuclei. This grade implies a high level of nuclear atypia and is a significant indicator of the tumor’s aggressiveness." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-BP-4999-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-B8-A54J-01Z-00-DX1.D9DA4491-BC23-4AA4-92CB-26956C78A034-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman nuclear grade for this tumor is Grade 2. This is based on the moderate variability in nuclear size and shape observed in the epithelial cells, indicating a level of moderate differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-B8-A54J-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BP-4974-01Z-00-DX1.97991078-9139-4bca-a5c7-0c6c66459df9-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman Nuclear Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman Nuclear Grade is III, indicating moderately pleomorphic nuclei with irregularity in size and shape but without extreme atypia. This grading suggests a moderate degree of nuclear abnormality, which corresponds to a level of aggressiveness in the tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-BP-4974-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A3-3349-01Z-00-DX1.206c2817-1b93-4fdf-8128-3f6e3b4935b6-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman grade of this renal cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman grade for this renal cell carcinoma is Grade 2. This is based on the nuclei being slightly larger than normal, with irregular contours and small nucleoli visible at high power magnification." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-A3-3349-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CZ-5468-01Z-00-DX1.e2bbe417-a24c-4511-934e-674221855695-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman nuclear grade of this carcinoma is grade 4. This grade indicates significant nuclear atypia often associated with pronounced pleomorphism, large nucleoli, and an aggressive tumor phenotype. Additionally, the sarcomatoid differentiation points to a high-grade transformation within the renal cell carcinoma, further confirming the aggressive nature of the malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-CZ-5468-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-B0-4827-01Z-00-DX1.c08eeafe-d2d4-41d1-a8f5-eacd1b0e601f-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this renal cell carcinoma according to Furman's nuclear grading?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma demonstrates a high histologic grade with Furman's nuclear grades ranging from II to IV. The varying degree of nuclear atypia suggests a progression of grade within the carcinoma, indicating a high grade and more aggressive tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-B0-4827-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-B0-5693-01Z-00-DX1.357ab4bd-c410-4843-96a2-8b6c5b56d9d6-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor exhibits a Fuhrman nuclear grade 2 of 4. This grading indicates mild nuclear pleomorphism, with nuclei showing slight variability in size and shape, primarily in the lower grades, reflecting a well-to-moderately differentiated tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-B0-5693-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-55-6984-01Z-00-DX1.d53e387a-9618-4486-98f3-a75604f25a7d-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as moderately differentiated. This grading reflects the glandular formations with moderate deviation from normal architecture and the moderate pleomorphism and mitotic activity observed in the tumor cells." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-55-6984-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-62-A46V-01Z-00-DX1.631E54D0-9E57-4932-B4EF-81820E56A95B-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor as observed from the slide?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is categorized as Grade 3 (G3), characterized by high-grade features such as pronounced nuclear atypia, significant pleomorphism, and potentially elevated mitotic activity, indicating rapid cell proliferation and suggesting a more aggressive clinical behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-62-A46V-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-55-7994-01Z-00-DX1.a0858080-c471-4337-bc57-7af57e9d92d8-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on the described features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as histologic grade 3. This indicates a poorly differentiated tumor, characterized by significant pleomorphism, prominent nucleoli, and focal necrosis. This high grade suggests an aggressive tumor with potentially challenging management needs." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-55-7994-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-86-8075-01Z-00-DX1.171bd8bd-af24-4770-b24b-732e675efd75-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the Nottingham grading system?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as moderately differentiated, corresponding to a Nottingham Histologic Grade of 2. This reflects moderate glandular differentiation, slight nuclear pleomorphism, and an intermediate rate of mitosis. This grade suggests a moderate level of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-86-8075-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-NJ-A55R-01Z-00-DX1.2E2B3642-4E1C-47DB-AF7B-988D586C0986-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this invasive adenocarcinoma based on the observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as histologic grade 2. This grading reflects the moderate differentiation of the glandular structures, the notable but controlled nuclear pleomorphism, and an intermediate mitotic rate. This grade indicates a moderately aggressive behavior, which impacts clinical management strategies." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-NJ-A55R-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-62-A46O-01Z-00-DX1.39B361AD-ED1D-4C0C-8611-0E8CCBDBD252-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This adenocarcinoma is classified as Grade 3 (G3), which indicates a poorly differentiated tumor. This grading is supported by the poor glandular differentiation, marked nuclear pleomorphism, and high mitotic activity seen in the slide. The Grade 3 classification suggests a more aggressive and invasive tumor, correlating with the observed histopathological features." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-62-A46O-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BG-A0VW-01Z-00-DX1.35FBE3EF-4892-42BF-8524-3DBAC00493F9-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO Grade of this endometrioid adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The FIGO Grade for this endometrioid adenocarcinoma is Grade 1. This grading is based on the well-differentiated architectural component and the moderate nuclear atypia, coupled with the absence of notable lymphovascular invasion. Grade 1 indicates a well-differentiated tumor with predictable behavior and a relatively favorable prognosis." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-BG-A0VW-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-D1-A16V-01Z-00-DX1.A9CF5591-0AC9-4384-9D8F-110FF3988236-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grade for this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as FIGO grade III. This grading reflects the high-grade nuclear atypia, marked pleomorphism, high mitotic activity, and significant architectural deviations from normal tissue." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-D1-A16V-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-EY-A2ON-01Z-00-DX1.F1B8DF0C-35F8-4FB7-A53C-1FCDDC5CFF4F-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grade for this carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is classified as FIGO Grade 3. This grading reflects the high-grade nature observed through severe nuclear pleomorphism, high mitotic index, and invasive characteristics. These factors align with an advanced grade of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-EY-A2ON-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-D1-A15V-01Z-00-DX1.D9A6C45F-3A6F-42D2-B102-0DEF43929B02-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grade of this papillary serous carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is classified as FIGO grade III. This indicates a high-grade tumor with significant atypical features, as evidenced by the complex papillary structures and marked nuclear pleomorphism observed in the slide." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-D1-A15V-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A2-A4S3-01Z-00-DX1.50699E65-E536-4C9B-93A7-4C9894624A29-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this infiltrating duct carcinoma based on the observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The infiltrating duct carcinoma is graded as Grade 3. This grading accounts for the high nuclear grade with marked variability in nuclear size and shape (nuclear grade 2), extensive mitotic activity indicative of rapid proliferation, and the degree of architectural disturbance. Grade 3 signifies a poorly differentiated tumor with aggressive characteristics, which aligns with the observations of high cellular proliferation and vascular invasion." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-A2-A4S3-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AR-A2LK-01Z-00-DX1.FBD59C38-CD4E-4C22-BC74-A57C192A9BBC-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nGiven the Nottingham grading system mentioned, what is the grading of this carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This carcinoma is graded as Nottingham Histologic Grade II, with a total score of 6 out of 9. This grading reflects the compromised tubular formation with a score of 3, moderate nuclear pleomorphism with a score of 2, and low mitotic activity with a score of 1. This intermediate grade suggests a moderately differentiated tumor with corresponding prognostic implications." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-AR-A2LK-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BH-A0C1-01Z-00-DX1.21FE357E-B182-4397-BFEF-7E96E994236A-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade 3, with a total score of 8 out of 9. This grading is based on the poor tubule formation (score of 3), marked nuclear pleomorphism (score of 3), and moderate mitotic activity (score of 2). This indicates a high-grade tumor with poor differentiation and suggests a potentially more aggressive clinical course." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-BH-A0C1-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this infiltrating lobular carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This infiltrating lobular carcinoma is classified as Nottingham Histologic Grade I. The grading is supported by the presence of tubular/glandular structures (score of 3/3), minimal nuclear pleomorphism (score of 1/3), and a low mitotic rate (score of 1/3), culminating in a total score of 5 out of 9. A Grade I designation indicates a well-differentiated tumor, suggestive of a lower grade of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-AR-A1AL-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A8-A06T-01Z-00-DX1.BA8B8FC3-6169-48C1-BE1F-37F140CB4D3B-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade 2 (NHG2). This grading reflects a moderate level of glandular/tubular differentiation, indicating the tumor maintains some normal tissue characteristics but also shows significant disruption. The moderate nuclear pleomorphism and mitotic activity contribute to the intermediate grade, aligning with the characteristics observed on the slide." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-A8-A06T-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BH-A0DS-01Z-00-DX1.38E82A1F-21B9-4B97-A304-15B886EA68A0-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this invasive ductal carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The invasive ductal carcinoma is classified as Nottingham Histologic Grade 2, with a total score of 7 out of 9. The grading is composed of a tubule formation score of 3, reflecting minimal differentiation, a nuclear grade of 3 indicating severe pleomorphism, and a high mitotic activity consistent with an elevated mitotic count score. This grade depicts a moderately differentiated form of carcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-BH-A0DS-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AC-A3OD-01Z-00-DX1.E19B311B-BAB1-4CE8-9421-B49D5BE4537E-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this invasive lobular carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This invasive lobular carcinoma is graded as Nottingham Histologic Grade 1. This grade reflects a well-differentiated tumor with a total score of 5 out of 9. The breakdown includes poor glandular/tubular formation (score of 3), minimal nuclear pleomorphism (score of 1), and a low mitotic rate (score of 1). The Grade 1 classification is indicative of a less aggressive tumor with a more favorable prognosis." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-AC-A3OD-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-E9-A1RD-01Z-00-DX1.34083668-cbd2-4610-b857-d50ee9f3e5bd-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade 2 (NHG2). This grading reflects the moderately differentiated glandular structures, indicating an intermediate level of differentiation. The variability in the nuclear features and the absence of high-grade features like extensive pleomorphism or necrosis further support a Grade 2 classification. This grade highlights an intermediate prognosis and suggests a careful consideration in determining treatment options." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-E9-A1RD-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-C8-A12Y-01Z-00-DX1.A15CB3E2-E145-4C75-8FEA-1DD503CD7C20-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of the infiltrating ductal carcinoma based on these features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The infiltrating ductal carcinoma is graded as moderately differentiated. This grading reflects the degree of glandular differentiation and the moderate level of nuclear atypia combined with the observed mitotic activity. The moderate differentiation indicates that the tumor retains some characteristics of the normal ductal structures but exhibits enough atypia to suggest a significant potential for aggressive behavior. The overall histological presentation supports a mid-grade categorization within carcinoma differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-C8-A12Y-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-C8-A134-01Z-00-DX1.78D10BCC-98B3-4587-897D-3E27DA28D2EB-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the nuclear grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified with a nuclear grade of 3. This grade reflects the marked nuclear pleomorphism, the significant degree of nuclear abnormalities including hyperchromatism and prominent nucleoli, and the presence of multinucleated giant cells. A nuclear grade of 3 denotes a high level of nuclear atypia, which suggests a poorly differentiated and aggressive tumor biology." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-C8-A134-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A8-A083-01Z-00-DX1.AD121BA9-B5FA-4A03-869B-8FE2C5014CE0-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade 1 (NHG1), reflecting a well-differentiated invasive ductal carcinoma. This grade encompasses well-formed glandular structures, minimal nuclear pleomorphism, and low mitotic activity. Grade 1 indicates a less aggressive tumor type with a favorable prognosis, aligning with the overall observed features in this slide." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-A8-A083-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A8-A08X-01Z-00-DX1.01FB49CC-6B8E-4317-8C42-6B6D81187A40-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this invasive ductal carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The grading reflects a high level of severity, given the poorly differentiated status of the carcinoma. While the specific system or score isn't provided, typically, such poorly differentiated tumors are assigned a higher grade reflecting their aggressive nature and poor differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-A8-A08X-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AR-A0U1-01Z-00-DX1.276433E7-E841-42D2-AF21-762F2FEA3B9B-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat Nottingham Histologic Grade is assigned to this tumor, and what does it indicate?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This tumor is graded as Nottingham Histologic Grade 3 of 3. This grading indicates a poorly differentiated carcinoma, characterized by minimal glandular formation, pronounced nuclear pleomorphism, and high mitotic activity. A Grade 3 designation signifies an aggressive malignancy, correlating with a potentially poorer prognosis and necessitating more intensive clinical management." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-AR-A0U1-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A2-A0CX-01Z-00-DX1.F07C75AB-E568-45CB-B497-37C712490393-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade assigned to this tumor based on the assessment?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade III, indicated by a total score of 8 out of 9. This high grade is determined by scoring poor tubular formation (3), marked nuclear pleomorphism (3), and moderate mitotic activity (2). A Grade III classification signifies a poorly differentiated tumor, correlating with a more aggressive and unfavorable prognosis." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-A2-A0CX-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BH-A0DE-01Z-00-DX1.64A0340A-8146-48E8-AAF7-4035988B9152-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade for this carcinoma, and what does this grading reflect?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is classified as Nottingham Histologic Grade 2 (NHG2) with a total score of 6 out of 9. This grading reflects poor glandular (tubular) formation, moderateness in nuclear pleomorphism, and a low rate of mitotic activity. An NHG2 designation indicates a moderately differentiated tumor, suggesting an intermediate level of aggressiveness and guiding treatment choices accordingly." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-BH-A0DE-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AC-A5XS-01Z-00-DX1.E5F2481E-9314-4B20-84B7-370EF82AF4BB-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow is this invasive lobular carcinoma graded according to the Nottingham system?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This invasive lobular carcinoma is graded as Nottingham Histologic Grade 1. This grading is determined by a tubular formation score of 3, indicating poor glandular differentiation, a nuclear pleomorphism score of 1, reflecting minimal variability in nuclear features, and a mitotic rate score of 1, indicating low level of cellular proliferation. These components collectively classify the tumor as low-grade, corresponding to a well-differentiated carcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-AC-A5XS-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-P5-A72W-01Z-00-DX1.0F26308D-5394-4499-AD5C-096B7608AF45-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this astrocytic tumor based on the observed characteristics?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as Grade III. This grading reflects the hypercellularity and significant nuclear atypia, aligning with the characteristics of a higher-grade astrocytic tumor, consistent with a more aggressive clinical course." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-P5-A72W-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-S9-A7IX-01Z-00-DX1.41EFC469-2139-44A6-AE48-76304EBD3F58-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this anaplastic astrocytoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The anaplastic astrocytoma is classified as WHO grade III. This grading reflects a high-grade tumor characterized by significant mitotic activity, pronounced pleomorphism, microvascular proliferation, and areas of necrosis, signifying a more aggressive clinical behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-S9-A7IX-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CS-6669-01Z-00-DX1.B1D9D967-ED63-48F7-9E9F-12B3E74EB0E8-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on the observed features using the WHO scale?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This tumor is graded as WHO Grade II of IV. This grading is based on the low presence of mitotic figures, absence of significant nuclear atypia, lack of necrosis, and the general low-grade behavior observed in the tumor cells. These features correlate with a less aggressive nature typical of a WHO Grade II oligodendroglioma." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-CS-6669-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-S9-A6TS-01Z-00-DX1.A10361F8-6208-44EE-9B2E-8513EBA31ED3-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this anaplastic astrocytoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This anaplastic astrocytoma is classified as WHO Grade III. The increased mitotic activity and proliferation index greater than 8% contribute to this designation, indicating a more aggressive and malignant tumor behavior typical of Grade III astrocytic tumors." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-S9-A6TS-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DH-A66G-01Z-00-DX1.82A4242B-EAB4-4474-B5C9-27FD5C322201-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This tumor is classified as WHO Grade III, indicating it is an anaplastic oligodendroglioma. This grading reflects the increased cellularity, mitotic activity, and aggressive nature of certain regions, despite the absence of extensive necrosis." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-DH-A66G-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-TQ-A7RG-01Z-00-DX1.71465600-F24A-4831-BA01-68A8C95F2BE9-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on your observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Grade II according to the World Health Organization (WHO) grading system. This grading reflects the low mitotic activity and absence of features such as microvascular proliferation or necrosis, indicating a low-grade, relatively non-aggressive neoplasm." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-TQ-A7RG-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AG-3901-01Z-00-DX1.3deb3ae7-a068-4d4b-868d-5507582c5e82-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this mucinous adenocarcinoma based on your observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This mucinous adenocarcinoma is graded as moderately differentiated (G2). This grading is supported by the moderate glandular differentiation, noticeable nuclear pleomorphism, and the cellular arrangement producing mucin, all of which align with a moderate degree of differentiation. This grading suggests a tumor with intermediate aggressiveness in terms of behavior and cellular abnormalities." | |
| } | |
| ], | |
| "image": [ | |
| "./READ/TCGA-AG-3901-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-EI-6509-01Z-00-DX1.3676fab0-3e79-4b57-b592-c1af5aee40f6-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of the adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as G2, reflecting a moderately differentiated tumor. This indicates an intermediate level of differentiation with the presence of tubulopapillary patterns and varying glandular formations, suggestive of a moderate degree of tumor progression." | |
| } | |
| ], | |
| "image": [ | |
| "./READ/TCGA-EI-6509-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AH-6643-01Z-00-DX1.054a48b8-a5f3-4c9b-bd2e-5d48c55d57af-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as moderately differentiated. This grading reflects the moderate level of glandular differentiation observed, with some architectural stability amidst the invasive behavior. Despite significant invasion, the tumor maintains intermediate characteristics between well-differentiated and poorly differentiated adenocarcinomas." | |
| } | |
| ], | |
| "image": [ | |
| "./READ/TCGA-AH-6643-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-GS-A9TX-01Z-00-DX1.5A1B7A1F-76EE-4E63-92C1-44AD0523F37B-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nIs there any specific grading for this type of lymphoma mentioned in the provided details?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "There is no specific grading provided for this case of diffuse large B-cell lymphoma in the observed details. Grading is typically not applied in the same manner for lymphomas as it is for solid tumors." | |
| } | |
| ], | |
| "image": [ | |
| "./DLBC/TCGA-GS-A9TX-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-2A-AAYO-01Z-00-DX1.A5BB3437-956A-4A42-AC28-1217B8016970-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason Score of this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor has a Gleason Score of 3+47. This score reflects the prevalence of pattern 3, which is moderately differentiated, along with areas of pattern 4 that are poorly differentiated. This combination suggests an intermediate-grade carcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-2A-AAYO-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-J4-A83K-01Z-00-DX1.7A8B686F-E4E3-48DF-8761-9B3923D38463-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score of this prostate adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score for this prostate adenocarcinoma is 3+36. This score indicates the tumor has a well-differentiated pattern, with glandular structures being relatively well-formed despite the mild atypia. The score reflects a lower-grade tumor according to the Gleason grading system." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-J4-A83K-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-KK-A7AW-01Z-00-DX1.F8A3E0D5-AC32-4C57-8AE2-5B98790544E7-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score for this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score for this tumor is 7, with a primary pattern of 4 and a secondary pattern of 3. This indicates poorly formed glands with fused or cribriform structures and moderate deviation in glandular formation, reflecting an intermediate grade of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-KK-A7AW-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-V1-A8WS-01Z-00-DX1.78D6CA57-E1DB-4583-8A71-676FE5819C73-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this prostatic adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as Gleason grade 3+3, with a score of 6, indicating moderate differentiation due to the uniformity of the gland formations and the lack of significant nuclear atypia." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-V1-A8WS-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-EJ-5510-01Z-00-DX1.ab391b79-7b8f-4ad8-b5bd-c868effa75f8-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score and grading for this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is assigned a Gleason score of 4+37, with a histologic grade indicating poorly differentiated to undifferentiated features. This score reflects a significant presence of Gleason pattern 4, which contributes to the aggressive nature of the tumor despite the lesser presence of pattern 3 architecture." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-EJ-5510-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-EJ-5511-01Z-00-DX1.45a97ef9-90fb-400d-9bdb-ebe8776e228b-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason grading of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor has a Gleason score of 3+47, indicating a moderate to high degree of architectural distortion. A tertiary pattern 6 reflects additional variations in tumor patterning, contributing to the complex morphology observed. This score underscores a moderate to high-grade malignancy requiring careful clinical management." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-EJ-5511-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-EJ-5499-01Z-00-DX1.bda3d0ed-5295-40c2-b23f-d60caaa03643-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score for this tumor, and what does it indicate?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score is recorded as 4+37, indicating that the most prevalent pattern (4) is poorly formed or fused glands, while pattern 3 presents slightly better-differentiated glandular structures. There's also a minor component of pattern 5 noted, which suggests a small presence of more aggressive, non-glandular formations. A score of 7 points to an intermediate-grade tumor, indicating a moderate level of aggressiveness." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-EJ-5499-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-KK-A6E2-01Z-00-DX1.6FD46FC9-EE08-41C0-A11E-B4AEF7AA4B38-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason grade of this prostatic adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The prostatic adenocarcinoma is graded as Gleason pattern 3+4. This grading reflects the irregular glandular structures with some showing cribriform appearance and areas of individual cell necrosis. The combination of these patterns indicates a moderately differentiated tumor with a potential for aggressive behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-KK-A6E2-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-G9-6370-01Z-00-DX1.6350a132-43b7-4b2e-9c83-23e7f00b60ff-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason grading of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as Gleason grade 3+4, with a combined score of 7 out of 10. This grade indicates a mixture of well-formed glands (pattern 3) and more poorly formed or fused glands (pattern 4), which reflects an intermediate level of differentiation and correlates with a moderate degree of aggressive behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-G9-6370-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-2H-A9GK-01Z-00-DX1.8C5C5BF2-4BB9-43B2-8F75-3B2782255C29-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as moderate to poorly differentiated. This grading reflects the variable tubule formation and the degree of nuclear pleomorphism observed, indicating a more aggressive tumor with disturbed architecture and increased proliferative activity." | |
| } | |
| ], | |
| "image": [ | |
| "./ESCA/TCGA-2H-A9GK-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-VR-A8ET-01Z-00-DX1.D9A85EDA-4258-4762-B894-8F7F1E30CEF6-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the histologic grade of this squamous cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The squamous cell carcinoma is classified as Histologic Grade G2, which indicates moderate differentiation. This grading correlates with the observed moderate differentiation of the squamous epithelial cells and the moderate level of nuclear pleomorphism and mitotic activity. The grading reflects the tumor’s intermediate level of aggressiveness." | |
| } | |
| ], | |
| "image": [ | |
| "./ESCA/TCGA-VR-A8ET-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BA-A8YP-01Z-00-DX1.03B95E63-2639-49F6-B8DD-AC2C2FA872B1-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the tumor grading based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as moderately differentiated. This grading reflects the moderate nuclear pleomorphism, focal keratinization, and the evident but not excessive mitotic activity, indicating a moderate level of differentiation. These features align with a moderate grade of squamous cell carcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./HNSC/TCGA-BA-A8YP-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-P3-A5QF-01Z-00-DX1.EC33D817-A9FF-4406-9FE4-12D0F37AA189-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow is the grading of this carcinoma determined based on the slide?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is graded as moderately differentiated. This grading is determined by observing the cellular organization, where the squamous cells form sheets and nests, reflecting some retention of differentiation, yet with clear invasive qualities and significant surrounding tissue involvement." | |
| } | |
| ], | |
| "image": [ | |
| "./HNSC/TCGA-P3-A5QF-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-T2-A6WZ-01Z-00-DX1.52078A9C-735F-4781-999E-3B65EA1C4174-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat can you say about the grading of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor demonstrates features of well to moderately differentiated squamous cell carcinoma. This indicates a range in differentiation from well-formed squamous features to those that are less organized, suggesting variability in aggressiveness across the tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./HNSC/TCGA-T2-A6WZ-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CN-6996-01Z-00-DX1.b3a1162b-9adb-4fb2-b472-5b9781b9364d-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The grading is moderately differentiated, reflecting the level of cellular atypia and keratinization observed. The degree of differentiation indicates a balance between aggressive behavior and some degree of retained squamous characteristics." | |
| } | |
| ], | |
| "image": [ | |
| "./HNSC/TCGA-CN-6996-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-UW-A72L-01Z-00-DX1.0A459BE8-D799-441D-85C0-B02AF6EDC806-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the nuclear grade of this tumor based on the provided details?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The nuclear grade of this tumor is 2 out of 4. This reflects moderate nuclear pleomorphism, indicating an intermediate level of nuclear atypia, aligning with the observed histological features." | |
| } | |
| ], | |
| "image": [ | |
| "./KICH/TCGA-UW-A72L-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-KO-8410-01Z-00-DX1.95A5FA25-6C01-478E-8CAB-20DF56E8D01C-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor exhibits Fuhrman nuclear grade 3 characteristics. This grading reflects significant variability in nuclear size and shape, along with the presence of prominent nucleoli, which indicates a higher level of nuclear atypia and malignancy aggression." | |
| } | |
| ], | |
| "image": [ | |
| "./KICH/TCGA-KO-8410-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-25-2404-01Z-00-DX1.7193B185-31C3-41D0-9194-86DEDF15F096-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grade of this invasive ductal carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This invasive ductal carcinoma can be graded as Nottingham Histologic Grade 3. The grading reflects poor glandular or tubular formation (score of 3), severe nuclear pleomorphism (score of 3), and a high mitotic index (score of 3), collectively indicating a poorly differentiated, aggressive tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./OV/TCGA-25-2404-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-WE-A8K4-01Z-00-DX1.C2B24058-E4F7-4AE2-9527-7BF524A6C3F3-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score for this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score for this adenocarcinoma is 4+48. This score signifies a high-grade tumor, with patterns characterized by poorly formed or fused glands. The additional presence of a tertiary pattern 5 further underscores the severity, as it consists of single cells or solid sheets, indicating a highly aggressive nature." | |
| } | |
| ], | |
| "image": [ | |
| "./SKCM/TCGA-WE-A8K4-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BF-A3DM-01Z-00-DX1.531B67D8-67DB-4729-B5E1-74304CF431FE-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this melanoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This melanoma is classified as histological grade 3. This grading reflects the high degree of pleomorphism, the presence of extensive necrosis within the tumor, and the aggressive growth pattern of the melanocytic cells extending into the deeper dermis. This high grade indicates a poorly differentiated and aggressive tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./SKCM/TCGA-BF-A3DM-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-W2-A7HC-01Z-00-DX1.828FAF66-6AF3-4EA7-ADD2-5C832077F8B8-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat grading system would you apply to this case, if any?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "In this context, no specific grading system is provided in the description. Typically, further assessments including clinical correlation and additional tests might inform grading, given the potential aggressive nature indicated by vascular invasion." | |
| } | |
| ], | |
| "image": [ | |
| "./PCPG/TCGA-W2-A7HC-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DX-A1KY-01Z-00-DX1.0523F0DD-BDCB-479B-836E-CCAB52D051F0-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this dedifferentiated liposarcoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This dedifferentiated liposarcoma is classified as high-grade due to the predominance of poorly differentiated cells, extensive areas of necrosis, and aggressive histological features such as the malignant fibrous histiocytoma-like growth pattern. The high-grade characteristics suggest a more aggressive clinical behavior and potential for metastasis." | |
| } | |
| ], | |
| "image": [ | |
| "./SARC/TCGA-DX-A1KY-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-IR-A3LA-01Z-00-DX1.D468114A-B28D-4F61-9582-2D0FC9BDA922-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat can you tell us about the tumor's grade based on your observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is moderately differentiated, indicating an intermediate grade. The papillary structures with focal necrosis and the presence of vascular invasion align with this moderate level of differentiation, suggesting a potentially aggressive clinical course that warrants careful management." | |
| } | |
| ], | |
| "image": [ | |
| "./CESC/TCGA-IR-A3LA-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DR-A0ZM-01Z-00-DX1.74DA4FCA-3876-4C06-85B9-D20456B89903-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat can you tell me about the grading of this carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The carcinoma is graded as moderately differentiated. This reflects the moderate nuclear pleomorphism and mitotic activity, indicating an intermediate level of differentiation and aggressiveness. This grade suggests a tumor that retains some features of the original squamous cells but exhibits significant abnormal growth behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./CESC/TCGA-DR-A0ZM-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-VS-A9V4-01Z-00-DX1.F71A69E3-050E-4CA9-A074-BAA03739D542-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow would you describe the grade based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The slide indicates a moderately differentiated mucinous adenocarcinoma. This grading reflects the moderate degree of glandular differentiation observed, alongside the significant necrotic changes, which suggest an intermediate level of tumor aggression and differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./CESC/TCGA-VS-A9V4-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-NA-A4QW-01Z-00-DX1.37801BA0-624E-47FB-99ED-219D4F22E36C-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grading of this tumor, as indicated in the findings?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as FIGO Grade 3. This grading suggests a high-grade tumor, characterized by severe atypical features and aggressive histological components, without necessarily implying widespread invasion or vascular infiltration as observed in this particular case." | |
| } | |
| ], | |
| "image": [ | |
| "./UCS/TCGA-NA-A4QW-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-OR-A5J5-01Z-00-DX1.4ED45C49-BD89-4DF0-BF92-37E79A3D244C-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adrenocortical carcinoma based on the Weiss score?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Weiss score for this adrenocortical carcinoma is 4. This score is indicative of certain features that align with aggressive behavior, such as capsular invasion and significant areas of necrosis, despite the absence of atypical mitoses and low mitotic activity." | |
| } | |
| ], | |
| "image": [ | |
| "./ACC/TCGA-OR-A5J5-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-K4-A3WU-01Z-00-DX1.DD4CA7B4-7950-4B7A-820A-74C763AFAE65-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nCan you explain the Gleason score observed in this case?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score for this urothelial carcinoma is 3+2, totaling 6 out of 10. This score reflects moderately differentiated glandular structures, suggesting a tumor with intermediate differentiation. The Gleason score helps in assessing the aggressiveness of the tumor, and in this case, indicates a moderately aggressive prognosis. There is no treatment effect or perineural or vascular invasion observed in this specimen, offering a snapshot of the tumor's natural history." | |
| } | |
| ], | |
| "image": [ | |
| "./BLCA/TCGA-K4-A3WU-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-XF-AAMZ-01Z-00-DX1.05AB4629-F59E-4877-B7F3-CF4336557EE0-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this urothelial carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The urothelial carcinoma is graded as a high grade, specifically grade 4/4, reflecting the poorly differentiated nature of the papillary structures, significant nuclear pleomorphism, and the aggressive invasive pattern extending into perivesical soft tissue. This grade underscores the carcinoma's aggressive characteristics and higher risk of progression and dissemination." | |
| } | |
| ], | |
| "image": [ | |
| "./BLCA/TCGA-XF-AAMZ-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-XF-A9ST-01Z-00-DX1.C135C4EB-6A64-4B9E-A8A0-87B72594568C-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this transitional cell carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This transitional cell carcinoma is graded as high grade, specifically 3-4/4. This grading reflects the pronounced nuclear atypia, high mitotic activity, extensive necrosis, and invasive growth pattern observed in the slide." | |
| } | |
| ], | |
| "image": [ | |
| "./BLCA/TCGA-XF-A9ST-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-GC-A3RB-01Z-00-DX1.C0011A55-EA8A-436B-BBCA-342B96803B22-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of these tumors based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The urothelial carcinoma is graded as Grade 3 out of 3, indicating a high-grade tumor with significant cellular disorganization. The prostatic adenocarcinoma has a Gleason score of 6 (3+3), reflecting a moderately differentiated tumor with small glandular structures." | |
| } | |
| ], | |
| "image": [ | |
| "./BLCA/TCGA-GC-A3RB-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AD-6548-01Z-00-DX1.4e047481-8926-48e6-9eba-46597c4cc396-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nGiven the details provided, what is the grading of this adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as moderately differentiated. This grading reflects the moderate deviation from normal architecture, moderate nuclear pleomorphism, and moderate mitotic rate. These factors suggest a middle-grade tumor that retains some glandular formation but also exhibits characteristics of more aggressive behavior, particularly in terms of invasion depth." | |
| } | |
| ], | |
| "image": [ | |
| "./COAD/TCGA-AD-6548-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-A6-6654-01Z-00-DX1.ed491b61-7c44-4275-879b-22f8007b5ff1-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This adenocarcinoma is classified as moderately differentiated. The glandular structures exhibit moderate differentiation, with some preservation of normal architecture, alongside moderate nuclear pleomorphism and mitotic activity. These characteristics align with a moderate grade of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./COAD/TCGA-A6-6654-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-NH-A50T-01Z-00-DX1.4624B690-C0DE-42BD-852C-6EBABF40255F-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the pathological grade of this adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is described as moderately differentiated, which places it at a Grade 2 level. This reflects intermediate differentiation, moderate nuclear pleomorphism, and a moderate rate of mitotic activity, suggesting a moderate level of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./COAD/TCGA-NH-A50T-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-NH-A8F8-01Z-00-DX1.0C13D583-0BCE-44F7-A4E6-5994FE97B99C-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as a low-grade adenocarcinoma due to the moderate level of differentiation observed in the glandular structures, which resemble normal colonic epithelium. This grading implies that the tumor cells still retain some structural characteristics of their cells of origin, indicating a less aggressive behavior compared to higher-grade tumors." | |
| } | |
| ], | |
| "image": [ | |
| "./COAD/TCGA-NH-A8F8-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BH-A0C0-01Z-00-DX1.2D32D35A-EB7E-4D0E-BE5F-E56F7B930463-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade 3, with a total score of 9 out of 9. It scores a 3 for poor tubular formation, a 3 for marked nuclear pleomorphism, and a 3 for high mitotic activity, indicating a poorly differentiated, high-grade carcinoma. This grading underscores an aggressive tumor behavior and the need for comprehensive clinical management." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-BH-A0C0-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BP-5190-01Z-00-DX1.1bc4a76e-f264-45fc-ad34-6c77593c4cc4-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman Nuclear Grade based on your observations?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman Nuclear Grade is identified as Grade III, characterized by a notable increase in nuclear size, marked pleomorphism, and prominent nucleoli, which are indicative of a high nuclear grade." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-BP-5190-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-Q1-A6DV-01Z-00-DX1.A31CD86F-703A-462F-8608-E7729607A325-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is graded as a grade 2 differentiation. This reflects moderate differentiation of the epithelial cells, which indicates an intermediate level of resemblance to the cells of origin, representing a moderately aggressive form of the tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./CESC/TCGA-Q1-A6DV-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-V1-A9O5-01Z-00-DX1.60716099-2E50-4D15-B9B4-A34F5B6BE3CC-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score for this prostatic carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score is 5+4. The primary pattern of 5 indicates a lack of glandular formation, while the secondary pattern of 4 represents fused glands with some architectural complexity, collectively indicative of a poorly differentiated carcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-V1-A9O5-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CG-4305-01Z-00-DX1.65167641-c270-4763-8bb8-cadedb17279d-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nIf applicable, what is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is classified as moderately to poorly differentiated. This reflects the mix of glandular structures with varying differentiation levels, along with the high degree of pleomorphism and increased mitotic rate observed in the slide." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-CG-4305-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BP-5191-01Z-00-DX1.4942ebf2-cef3-4cff-8430-b377d274952f-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman Nuclear Grade of this renal cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman Nuclear Grade is IV. This is characterized by large, pleomorphic nuclei with prominent and often irregular nucleoli, indicating a high grade of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-BP-5191-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-SU-A7E7-01Z-00-DX1.1C4CB02E-100C-4A40-8C98-55F21C6CEE30-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score of this tumor is 8, with a primary pattern of 5, characterized by poorly differentiated solid and fused glandular formations, and a secondary pattern of 3, showing moderately formed glands. This score reflects a high-grade cancer with potential for aggressive behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-SU-A7E7-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AX-A05S-01Z-00-DX1.2C0EC24F-086C-4C96-9955-676D43996443-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as FIGO Grade 3. This grading reflects the poorly differentiated nature of the tumor, characterized by a predominantly solid growth pattern, significant nuclear pleomorphism, and high mitotic activity. All these factors contribute to the classification as a high-grade malignancy with a potentially aggressive clinical course." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-AX-A05S-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-AX-A05S-01Z-00-DX2.5B5A8CD0-2DCE-47F0-AC68-CF459FB922CF-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as FIGO Grade 3. This grading reflects the poorly differentiated nature of the tumor, characterized by a predominantly solid growth pattern, significant nuclear pleomorphism, and high mitotic activity. All these factors contribute to the classification as a high-grade malignancy with a potentially aggressive clinical course." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-AX-A05S-01Z-00-DX2.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-21-1070-01Z-00-DX1.06363f8a-ef29-4d73-95da-a3172d7873c0-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The grading corresponds to poorly differentiated due to the marked nuclear pleomorphism, high mitotic activity, and the aggressive pattern of invasion seen. This indicates a high-grade tumor, reflecting its potential for aggressive clinical behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-21-1070-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BR-7723-01Z-00-DX1.15f75a3f-93b8-423f-b5b5-bdb5ef378ed8-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the histologic grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This tumor is classified as histologic grade G3, indicating poor differentiation. The grade reflects the disorganized architecture, significant atypia in cellular morphology, and aggressive characteristics observed throughout the slide. This higher grade suggests a more aggressive malignancy with poor differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-BR-7723-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-C5-A2M1-01Z-00-DX1.E03FE8EC-002B-4673-ACC5-A32F1CA94A98-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as moderately differentiated adenocarcinoma (Grade II). This denotes a moderate level of differentiation, with the tumors maintaining some glandular structures but also displaying areas with a more solid appearance, combined with increased cellular proliferation." | |
| } | |
| ], | |
| "image": [ | |
| "./CESC/TCGA-C5-A2M1-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-23-1028-01Z-00-DX1.117B4B7B-F796-4D33-A645-CD80E5C43E6D-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this ovarian adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This ovarian adenocarcinoma is classified as Grade III. The grading reflects the high degree of anaplastic differentiation, extensive lymphovascular invasion, and significant necrosis, all of which indicate a poorly differentiated and aggressive tumor. The Grade III designation highlights the malignancy's potential for aggressive behavior and spread." | |
| } | |
| ], | |
| "image": [ | |
| "./OV/TCGA-23-1028-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-D1-A17C-01Z-00-DX1.8A939640-D0B7-4537-8B46-4EEA4B4494F6-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the FIGO grading of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as FIGO grade I. This low-grade classification is based on the well-differentiated glandular structures, mild nuclear pleomorphism, and minimal mitotic activity, all indicative of a less aggressive form of endometrial adenocarcinoma." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-D1-A17C-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-D1-A177-01Z-00-DX1.C2BC53F3-F7D7-4ED0-93BB-303A4D8AE602-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow would you grade this tumor based on the FIGO system?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as FIGO grade II. This grading is characterized by moderate glandular differentiation and moderate nuclear atypia, indicating an intermediate level of aggressiveness and differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./UCEC/TCGA-D1-A177-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CZ-4854-01Z-00-DX1.d44fdcf0-6f83-4792-aedb-d6efc97fce21-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade of this clear cell carcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Fuhrman nuclear grade of this clear cell renal cell carcinoma is Grade II. This is characterized by moderate variability in nuclear size and shape, indicating a relatively low nuclear grade and suggesting a better prognosis compared to higher-grade tumors." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-CZ-4854-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-CZ-5456-01Z-00-DX1.65910977-0870-43cf-8a78-91dd8a289312-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Fuhrman nuclear grade for this tumor based on the observation?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor corresponds to a Fuhrman nuclear grade of 2. This grading is based on the round to oval nuclei with prominent nucleoli. This intermediate grade suggests moderate nuclear atypia, providing insight into the tumor's biological behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./KIRC/TCGA-CZ-5456-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DB-A4X9-01Z-00-DX1.D877E4C5-87FA-4289-BDEB-883F6408C094-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow would you grade this tumor based on the presented information?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as WHO Grade II, which designates it as a low-grade neoplasm. This is due to the low mitotic activity and absence of high-grade features such as endothelial hyperplasia, neovascular proliferation, and necrosis, aligning with the characteristics of a less aggressive tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-DB-A4X9-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-DB-A4X9-01Z-00-DX2.1C5A66A2-48A5-41B3-98C7-6B668438C4C1-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nHow would you grade this tumor based on the presented information?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is graded as WHO Grade II, which designates it as a low-grade neoplasm. This is due to the low mitotic activity and absence of high-grade features such as endothelial hyperplasia, neovascular proliferation, and necrosis, aligning with the characteristics of a less aggressive tumor." | |
| } | |
| ], | |
| "image": [ | |
| "./LGG/TCGA-DB-A4X9-01Z-00-DX2.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Nottingham Histologic Grade of this tumor?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor is classified as Nottingham Histologic Grade 3, which reflects its highly aggressive nature. This grading accounts for poor formation of tubular structures, marked nuclear pleomorphism, and a moderate mitotic count, culminating in a high-grade tumor with a total score that suggests a less favorable prognosis, necessitating aggressive treatment and management." | |
| } | |
| ], | |
| "image": [ | |
| "./BRCA/TCGA-GM-A2DH-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-85-8351-01Z-00-DX1.E3340212-A6C4-4CB4-89A3-E632D3481BE4-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this squamous cell carcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This squamous cell carcinoma is graded as Grade 2, which corresponds to a moderately differentiated tumor. This grading is based on the observed moderate differentiation of the tumor cells, characterized by moderate nuclear pleomorphism and keratinization, without any evidence of necrosis or vascular invasion. The moderate differentiation indicates that the tumor retains some features of the original squamous cells but with clear malignant characteristics." | |
| } | |
| ], | |
| "image": [ | |
| "./LUSC/TCGA-85-8351-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-BR-8363-01Z-00-DX1.eeecad72-b281-4e28-be60-4542b4a275aa-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat would be the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "This adenocarcinoma is graded as poorly differentiated. The lack of glandular differentiation, pronounced nuclear pleomorphism, and high mitotic index collectively indicate a high-grade tumor, suggesting a more aggressive clinical behavior." | |
| } | |
| ], | |
| "image": [ | |
| "./STAD/TCGA-BR-8363-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-XJ-A83F-01Z-00-DX1.11A9B6FC-16AB-44F2-B93E-7806693D90F7-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason Grade of this prostatic adenocarcinoma?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The tumor has a Gleason score of 7, with a primary pattern of 3 and a secondary pattern of 4. This indicates a moderately differentiated prostate adenocarcinoma, with the primary pattern demonstrating more structured gland formation and the secondary pattern indicating areas with more significant disorganization." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-XJ-A83F-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-44-A47G-01Z-00-DX1.810F67EC-3A0C-4056-B736-3331A11412CC-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the grading of this adenocarcinoma based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The adenocarcinoma is classified as moderately differentiated, corresponding to Grade 2. This grade reflects the intermediate level of glandular formation and atypical cell morphology, indicating a moderate level of cellular differentiation." | |
| } | |
| ], | |
| "image": [ | |
| "./LUAD/TCGA-44-A47G-01Z-00-DX1.h5" | |
| ] | |
| }, | |
| { | |
| "id": "TCGA-KK-A8I7-01Z-00-DX1.18EFAFFF-7E7C-4072-8137-7D04FB687B4A-4", | |
| "conversations": [ | |
| { | |
| "from": "human", | |
| "value": "<image>\nWhat is the Gleason score of this tumor based on the observed features?" | |
| }, | |
| { | |
| "from": "gpt", | |
| "value": "The Gleason score for this tumor is 9, with a pattern of 4+5. This score reflects the poorly differentiated nature of the glandular structures and the aggressive characteristics observed, such as high nuclear pleomorphism and increased mitotic activity, contributing to a high grade of malignancy." | |
| } | |
| ], | |
| "image": [ | |
| "./PRAD/TCGA-KK-A8I7-01Z-00-DX1.h5" | |
| ] | |
| } | |
| ] | |